Literature DB >> 16984499

Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study.

A Floreani1, G Niro, E Rosa Rizzotto, S Antoniazzi, F Ferrara, I Carderi, V Baldo, A Premoli, F Olivero, E Morello, M Durazzo.   

Abstract

BACKGROUND: Many reports of autoimmune hepatitis (AIH) were written in the 'pre-Hepatitis C era' and data on the natural history are still incomplete. AIM: To evaluate the clinical presentation and the natural history of type I AIH.
METHODS: Seventy-three consecutive patients with a regular follow-up of at least 2 years were prospectively included in the study. The mean follow-up was 91 +/- 61 months.
RESULTS: Patients with 'acute' onset at presentation were significantly older than patients with 'chronic' onset (P < 0.05) and had significantly higher serum levels of transaminase, gamma-glutamyltransferase and bilirubin; Prothrombin time was significantly lower in the said group compared with AIH patients with 'chronic' onset. In 4 of 63 (6.3%) female patients, AIH had the onset during pregnancy; in all of them the outcome of pregnancy was favourable. The major events during the follow-up included oesophageal varices (n = 9) and ascites (n = 4), and 60 patients remained in remission while receiving immunosuppression. None of the patients died during the follow-up, but seven patients were transplanted. The cumulative transplant-free probability of survival was 73.5% at 280 months.
CONCLUSIONS: Elderly patients have more frequently an acute onset at presentation. Survival in AIH is apparently good; with early diagnosis, and improved medical therapy, liver transplantation for AIH will become a rare event in future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984499     DOI: 10.1111/j.1365-2036.2006.03104.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  29 in total

1.  Autoimmune Hepatitis in Hawai'i.

Authors:  Tanner I Kim; Jaclyn E Kagihara; Naoky C S Tsai; Marina M Roytman
Journal:  Hawaii J Med Public Health       Date:  2015-08

Review 2.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 3.  Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.

Authors:  Aylin Tansel; Lior H Katz; Hashem B El-Serag; Aaron P Thrift; Mayur Parepally; Mohammad H Shakhatreh; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-12       Impact factor: 11.382

Review 4.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 5.  Challenges in the diagnosis and management of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Can J Gastroenterol       Date:  2013-09       Impact factor: 3.522

Review 6.  Recurrence of autoimmune liver diseases after liver transplantation.

Authors:  Nabiha Faisal; Eberhard L Renner
Journal:  World J Hepatol       Date:  2015-12-18

7.  Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.

Authors:  Lara Dakhoul; Keaton R Jones; Samer Gawrieh; Marwan Ghabril; Chelsey McShane; Raj Vuppalanchi; Eduardo Vilar-Gomez; Lauren Nephew; Naga Chalasani; Craig Lammert
Journal:  Dig Dis Sci       Date:  2019-01-07       Impact factor: 3.199

8.  Management of patients with difficult autoimmune hepatitis.

Authors:  Richard Parker; Ye Htun Oo; David H Adams
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

Review 9.  Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis.

Authors:  Takuya Watanabe; Kenji Soga; Haruka Hirono; Katsuhiko Hasegawa; Koichi Shibasaki; Hirokazu Kawai; Yutaka Aoyagi
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

10.  Type I autoimmune hepatitis presenting with acute liver failure in the setting of wild mushroom ingestion.

Authors:  Jason N Rogart; Anita Iyer; Marie E Robert; Gillian Levy; Mario Strazzabosco
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.